Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Houssein H Ayoub

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHOAdelina Artenie, Niklas Luhmann, Aaron G Lim, et al.
Journal of Global Health|March 1, 2021
Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19Houssein H Ayoub, Hiam Chemaitelly, Shaheen Seedat, et al.
Scientific Reports|September 15, 2021
SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in QatarShaheen Seedat, Hiam Chemaitelly, Houssein H Ayoub, et al.
BMJ Innovations|June 30, 2021
Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analysesHoussein H Ayoub, Hiam Chemaitelly, Monia Makhoul, et al.
Public Health|October 30, 2025
Estimating SARS-CoV-2 infection incidence and detection rates: Demonstrating a novel surveillance methodHoussein H Ayoub, Hiam Chemaitelly, Patrick Tang, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 3, 2026
Routine SARS-CoV-2 Testing Frequency and Risk of Severe COVID-19: A Nationwide Population-Based StudyLaith J Abu-Raddad, Houssein H Ayoub, Peter Coyle, et al.
Plos One|September 26, 2025
Evaluating the cost-effectiveness of COVID-19 mRNA primary-series vaccination in Qatar: An integrated epidemiological and economic analysisHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2020
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure SettingLaith J Abu-Raddad, Hiam Chemaitelly, Joel A Malek, et al.
Nature|February 5, 2025
Differential protection against SARS-CoV-2 reinfection pre- and post-OmicronHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Vaccine|July 30, 2025
Comparative effectiveness of one versus two doses of COVID-19 vaccines in Qatar: Evidence of converging protection over timeHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHOAdelina Artenie, Niklas Luhmann, Aaron G Lim, et al.
Journal of Global Health|March 1, 2021
Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19Houssein H Ayoub, Hiam Chemaitelly, Shaheen Seedat, et al.
Scientific Reports|September 15, 2021
SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in QatarShaheen Seedat, Hiam Chemaitelly, Houssein H Ayoub, et al.
BMJ Innovations|June 30, 2021
Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analysesHoussein H Ayoub, Hiam Chemaitelly, Monia Makhoul, et al.
Public Health|October 30, 2025
Estimating SARS-CoV-2 infection incidence and detection rates: Demonstrating a novel surveillance methodHoussein H Ayoub, Hiam Chemaitelly, Patrick Tang, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 3, 2026
Routine SARS-CoV-2 Testing Frequency and Risk of Severe COVID-19: A Nationwide Population-Based StudyLaith J Abu-Raddad, Houssein H Ayoub, Peter Coyle, et al.
Plos One|September 26, 2025
Evaluating the cost-effectiveness of COVID-19 mRNA primary-series vaccination in Qatar: An integrated epidemiological and economic analysisHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2020
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure SettingLaith J Abu-Raddad, Hiam Chemaitelly, Joel A Malek, et al.
Nature|February 5, 2025
Differential protection against SARS-CoV-2 reinfection pre- and post-OmicronHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Vaccine|July 30, 2025
Comparative effectiveness of one versus two doses of COVID-19 vaccines in Qatar: Evidence of converging protection over timeHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Pageof 8